Breaking News Headlines Today | Ground News

See every side of every news story

Pharmaceutical-technology.com image

News from pharmaceutical-technology.com

Ground News rates Pharmaceutical-technology.com’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Pharmaceutical-technology.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Pharmaceutical-technology.com

Where is Pharmaceutical-technology.com located?Pharmaceutical-technology.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaceutical-technology.com News

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump — ANGELA WEISS/AFP via Getty Images via Getty Images

Drug Prices · United States

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

50% Center coverage: 321 sources

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.See the Story

Senate again fails to pass bills aimed at funding government as blame game continues — REUTERS / pwu404

Government Shutdown · United States

Senate again fails to pass bills aimed at funding government as blame game continues

52% Center coverage: 213 sources

Senate Democrats voted Wednesday to block a House-passed stopgap funding bill that would reopen the federal government until Nov. 21, but several Democrats broke with Senate Democratic Leader Chuck Schumer (N.Y.) and supported the measure. See the Story

FDA Approves Maintenance Combo for Small Cell Lung Cancer

FDA · United States

FDA Approves Maintenance Combo for Small Cell Lung Cancer

80% Center coverage: 5 sources

(MedPage Today) -- The FDA approved lurbinectedin (Zepzelca) plus either atezolizumab (Tecentriq) or atezolizumab and hyaluronidase (Tecentriq Hybreza) as first-line maintenance therapy for extensive-stage small cell lung cancer, the agency announced...See the Story

Breaking News Topics Related to Pharmaceutical-technology.com